What is the highest JNJ stock has ever been?

Johnson & Johnson – 52 Year Stock Price History | JNJ

Table of Contents

The all-time high Johnson & Johnson stock closing price was 186.01 on April 25, 2022.
The Johnson & Johnson 52-week high stock price is 186.69, which is 0.4% above the current share price.

When was the last time JNJ stock split?

1996
The last stock split announced by Johnson & Johnson was in 1996, when shares were split 2-for-1. On April 17, Johnson & Johnson announced sales and earnings for the first quarter of 2001. Sales of $7.8 billion and net earnings of $1.5 billion increased by 6.5% and 14.2%, respectively, over first-quarter 2000 results.

Who are Johnson and Johnson competitors?

Johnson & Johnson competitors include Bristol Myers Squibb, Merck, Unilever, Pfizer and Procter & Gamble.

What is the stock symbol for Tylenol?

JNJ
JNJ Stock Price | Johnson & Johnson Stock Quote (U.S.: NYSE) | MarketWatch.

Is JNJ a good stock to buy?

JNJ boasts an average earnings surprise of 7.8%. With strong earnings growth, a good Zacks Rank, and top-tier Momentum and VGM Style Scores, investors should think about adding JNJ to their portfolios.

What happens to my JNJ stock after the split?

Rachel Warren: If you currently own shares of Johnson & Johnson like I do, when the company splits, you will own shares of both Johnson & Johnson, the new pharmaceutical/medical device entity, as well as the new yet-to-be-named consumer health business.

What happens to JNJ stock when company splits?

Johnson & Johnson (JNJ) will split into two public companies within the next 18 to 24 months. One will get its many consumer brands, while the other will get its pharmaceuticals, medical devices, and medical technology businesses.

Is JNJ split in 2021?

Summary. JNJ announced they would be splitting the company into 2 separate businesses within the next 2 years. JNJ is built with a fortress balance sheet that has been able to pay a rising dividend for 59 consecutive years.

Is JNJ a good stock?

We can see that Johnson & Johnson does have institutional investors; and they hold a good portion of the company’s stock. This suggests some credibility amongst professional investors. But we can

Should you buy JNJ stock?

Johnson & Johnson is shaking off its stodgy image as it moves to develop a broad and underappreciated drug portfolio and spin off its consumer business. The stock, now priced around $173, trades for a reasonable 17 times projected 2022 earnings of $10.38 a

Is JNJ stock a buy or sell?

The Johnson & Johnson stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.

Why is JNJ stock falling?

The overall fundamentals underlying JNJ stock are a mixed bag. On the one hand, it has a super-stable business with exceptionally stable demand drivers, which tend to give JNJ a stable profit-growth outlook. On the other hand, demand for its products is gradually slowing, due to slowing economic growth. JNJ essentially has three major businesses.